% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Hruby:302992,
author = {L. Hruby and K. Schaal and A. Delaidelli and D. J.
Picard$^*$ and C. Dunham and O. Lewandowska and T. Reiff and
M. Larcher and C. Pouponnot and P. H. Sorensen and B.
Rotblat and G. Reifenberger$^*$ and M. Remke$^*$ and G.
Leprivier},
title = {{T}he {EIF}4{EBP}1 gene encoding 4{EBP}1 is
transcriptionally upregulated by {MYC} and linked to shorter
survival in medulloblastoma.},
journal = {Cell death discovery},
volume = {11},
number = {1},
issn = {2058-7716},
address = {London},
publisher = {Nature Publishing Group},
reportid = {DKFZ-2025-01439},
pages = {330},
year = {2025},
abstract = {Medulloblastoma (MB) is the most common malignant brain
tumor in childhood and is stratified into four molecular
groups ‒ Wingless and Int-1 (WNT), Sonic hedgehog (SHH),
Group 3 and Group 4. Group 3 MB patients exhibit the poorest
prognosis, with a 5-year overall survival of $<60\%,$
followed by Group 4 MB patients. Apart from MYC
amplification in a subset of Group 3 MBs, the molecular
pathomechanisms driving aggressiveness of these tumors
remain incompletely characterized. The gene encoding the
mTOR substrate and mRNA translation inhibitor eukaryotic
translation initiation factor 4E-binding protein 1
(EIF4EBP1) represents a possible MYC target gene whose
corresponding protein, 4EBP1, was shown to be more active in
Group 3 versus Group 4 MBs. However, the prognostic role of
4EBP1 in MB and the mechanisms supporting 4EBP1
overexpression in Group 3 MB are still elusive. We analyzed
EIF4EBP1 mRNA expression in publicly available data sets and
found an upregulation in MB as compared to non-neoblastic
brain. EIF4EBP1 mRNA expression levels were higher in Group
3 compared to Group 4 MBs. EIF4EBP1 mRNA expression was
correlated with MYC expression, most prominently in Group 3
MBs. Survival analyses highlighted that high EIF4EBP1 mRNA
expression was associated with reduced overall and
event-free survival across all MB patients and in Group
3/Group 4 MB patients. Immunohistochemical evaluation of
4EBP1 protein expression in MB tissues confirmed that high
levels of 4EBP1 are associated with poor outcome. Functional
analyses revealed that MYC directly regulates EIF4EBP1
promoter activity, providing a mechanism for increased
EIF4EBP1 mRNA levels in Group 3 MBs. Finally, we observed
that 4EBP1 may support colony formation of in vitro cultured
MB cells. Our data highlight that transcriptional
upregulation of EIF4EBP1 by MYC promotes in vitro
tumorigenicity of MB cells and associates with shorter
survival of MB patients.},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40670359},
pmc = {pmc:PMC12267489},
doi = {10.1038/s41420-025-02601-x},
url = {https://inrepo02.dkfz.de/record/302992},
}